Atzori L, Congiu L
Department of Toxicology, University of Cagliari, Italy.
Drug Metabol Drug Interact. 1996;13(2):87-98. doi: 10.1515/dmdi.1996.13.2.87.
The effects of verapamil, a calcium channel blocker, on allyl alcohol (AA) hepatotoxicity were studied in vivo. AA administration induced an increase of serum alanine aminotransferase (ALT) concentration and liver necrosis by means of glutathione (GSH) depletion. Pretreatment with verapamil reduced the increase of ALT in plasma and the morphological signs of necrosis induced by AA administration. Verapamil did not affect GSH levels by itself but prevented the decrease of the tripeptide by AA. In vitro, but not in vivo, verapamil inhibited the activity of alcohol dehydrogenase (ADH), the key enzyme in the conversion of AA into the toxic metabolite acrolein. These data indicate that verapamil protects against AA toxicity, probably by preventing the production of acrolein, its reactive metabolite.
在体内研究了钙通道阻滞剂维拉帕米对烯丙醇(AA)肝毒性的影响。给予AA会通过消耗谷胱甘肽(GSH)导致血清丙氨酸氨基转移酶(ALT)浓度升高和肝坏死。维拉帕米预处理可降低血浆中ALT的升高以及AA给药诱导的坏死形态学迹象。维拉帕米本身不影响GSH水平,但可防止AA导致的三肽减少。在体外而非体内,维拉帕米抑制乙醇脱氢酶(ADH)的活性,ADH是AA转化为有毒代谢产物丙烯醛的关键酶。这些数据表明,维拉帕米可能通过阻止其活性代谢产物丙烯醛的产生来预防AA毒性。